Market TrendsOct 11, 2026
Canadian recreational cannabis sales reached 5.52 billion CAD in 2024/2025
Statistics Canada's annual series reports 5,522,042,000 CAD in recreational cannabis sales for the fiscal year 2024/2025.
SOURCE / Statistics Canada
Independent intelligence / Canada SOURCE-VERIFIED · OCT 11, 2026
WEEDWATCH.
Canadian Cannabis Intelligence
Tracking Canada's cannabis industry through data, research and regulatory intelligence.
Primary-source reporting Transparent methodology Evidence in context
The intelligence briefing
All news Latest developments
RegulationJul 21, 2026
Health Canada clarifies indoor odour filtration expectations
Updated guidance distinguishes the requirement to have indoor air filtration from the documentation expected at the application stage.
SOURCE / Health Canada
BC CannabisJul 16, 2026
B.C. announces cannabis agreement with Gitanmaax Band
A July announcement describes a Section 119 agreement supporting Indigenous participation and shared public health and safety goals.
SOURCE / Government of British Columbia
Market intelligence
Canadian cannabis sales
Annual recreational market · CAD · fiscal year
$5.52B2024/2025
Statistics Canada · Table 10-10-0164-01 ↗Retrieved Oct 11, 2026 · Reporting through 2024/2025
The Canadian marketA clearer view of
A clearer view of
a changing industry.
Follow reported recreational cannabis sales across provinces and product categories. Every chart is grounded in official data, with its reporting period and methodology attached.
Open market intelligenceCoverage
4 fiscal years
2021/2022 – 2024/2025Observations
335
Published, non-suppressed valuesFederal licence register
Search directory Company intelligence
| Licence holder | Province | Licence categories | Verified | |
|---|---|---|---|---|
| Aurora Cannabis Enterprises Inc. (4th site) | British Columbia | Sale (Medical) | Oct 11, 2026 | |
| Nextleaf Labs Ltd. | British Columbia | Processing | Oct 11, 2026 | |
| Nextleaf Labs Ltd. (2nd site) | British Columbia | Micro-Processing | Oct 11, 2026 | |
| Pure Sunfarms Corp. (2nd site) | British Columbia | Processing · Cultivation | Oct 11, 2026 |
Licence-holder entries may represent separate sites. Names and categories follow Health Canada; corporate ownership is shown only where verified.
Science, with context
All research →From the research library
Public health and policy
Alberta hospitalization study found no increase attributable to legalization
Researchers examined Alberta adults across periods before legalization, after flower legalization and after legalization of edibles, extracts and topicals. They did not identify increased hospitalization risk associated with legalization in either younger or older adult groups.
Cohort study with interrupted time series analysis
May 19, 2024
Small CBD trial found no significant reduction in trauma-script reactivity
A trial in 42 trauma-exposed participants with elevated stress found no statistically significant reduction in anxiety, distress or heart-rate response to personalized trauma scripts, either after initial CBD administration or one week of repeated administration.
Randomized double-blind placebo-controlled trial
Jul 3, 2024
Preliminary human study examined d-limonene alongside THC
In a controlled vaporization study, the highest combined d-limonene and THC condition reduced some self-reported anxiety and paranoia ratings compared with THC alone. Other measured THC effects were unchanged.
Small double-blind placebo-controlled human laboratory study
Mar 13, 2024